Rabeprazole Sodium Tablet, Delayed Release
Product Images NDC 50090-4751

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Rabeprazole Sodium (NDC 50090-4751). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Rabe-str (Rabe Str)

FDA Label Image

Rabe-str2 (Rabe Str2)

This appears to be a chart showing the mean score for heartburn in a study involving a placebo and two doses of RAB (presumably a medication). The study was conducted over 28 days and heartburn was scored on a scale from 0 (no heartburn) to 4 (very severe heartburn).*

FDA Label Image

Rabe-str3 (Rabe Str3)

This appears to be a table representing the heartburn scores of a study with two groups, one receiving a placebo (n=58) and the other receiving RAB20mg (n=59). The table shows the study days (14, 7, 0, 7, 14, 21, 28) and the corresponding heartburn scores, with 0 indicating no heartburn and 4 indicating very severe heartburn.*

FDA Label Image

Rabe-str4 (Rabe Str4)

This appears to be a table for a study's mean score, comparing the scores for the placebo group ("PLACEBO") and a group treated with RAB20mg ("RAB20mg"). The table includes heartburn scores for study days (labeled as "jone"), with ratings from 0 ("none") to 4 ("very severe").*

FDA Label Image

Label Image (Lbl500904751)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.